Avricore Health Inc Stock Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Sales 2021 | 123K 89.12K | Sales 2022 | 1.77M 1.28M | Capitalization | 31.26M 22.69M |
---|---|---|---|---|---|
Net income 2021 | -1M -726K | Net income 2022 | - 0 | EV / Sales 2021 | 111 x |
Net cash position 2021 | 1.97M 1.43M | Net cash position 2022 | 591K 429K | EV / Sales 2022 | 17.3 x |
P/E ratio 2021 |
-8.67
x | P/E ratio 2022 |
-37.7
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.31% |
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Kiki Smith
DFI | Director of Finance/CFO | - | 19-08-05 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 16-01-19 |
Robert Sindelar
BRD | Director/Board Member | 71 | 18-03-26 |
Christine Hrudka
BRD | Director/Board Member | - | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |